BAY 94-9027 pediatric pharmacokinetics, safety, and efficacy trial

• Research type

  Research Study

• Full title

  A multi-center, phase III, non-controlled, open-label trial to evaluate the pharmacokinetics, safety, and efficacy of BAY 94-9027 for prophylaxis and treatment of bleeding in previously treated children (age <12 years) with severe hemophilia A

• IRAS ID

  120422

• Contact name

  Tina Biss

• Contact email

  Tina.biss@nuth.nhs.uk

• Sponsor organisation

  Bayer plc

• Eudract number

  2012-004434-42

• ISRCTN Number

  N/A

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  13/NE/0049

• Date of REC Opinion

  15 Apr 2013

• REC opinion

  Further Information Favourable Opinion